Ginsenoside Rg3 Catalog No.:M8771-10 Methods for treating oncovirus positive

Methods for treating oncovirus positive cancers

InChi: InChI=1S/C19H16N2O2S2/c1-13-3-8-17(9-4-13)25(22

leading to dramatic dose-dependent apoptosis

It has very weak or no activity targeting the other HDACs (2-40 µM)

BMS-3 is a specific and potent LIMK inhibitor with IC50 value of 5nM and 6nM for LIMK1 and LIMK2 respectively

Ginsenoside Rg3 Catalog No.:M8771-10 Methods for treating oncovirus positiveGinsenoside Rg3 is a K 7. 1 channel activator, 2 GABA A receptor agonist, and a 10 nAChR antagonist found in Panax. It exhibits a wide variety of biological activities, including decreasing expression of pro inflammatory cytokines, reducing oxidative stress, and inhibiting tubular formation and migration of endothelial progenitor cells. Product information CAS Number: 14197 60 5 Molecular Weight: 785. 01 Formula: C42H72O13 Synonym: 20(S) Ginsenoside